Skip to main content
Clinical Trials/NCT01071408
NCT01071408
Completed
Not Applicable

Development of a Stroke Prevention Program for an Underserved Minority Community

Sepulveda Research Corporation1 site in 1 country54 target enrollmentMarch 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Ischemic Stroke
Sponsor
Sepulveda Research Corporation
Enrollment
54
Locations
1
Primary Endpoint
Blood pressure control
Status
Completed
Last Updated
13 years ago

Overview

Brief Summary

The purpose of this study is to determine whether an outpatient program can reduce the risk of recurrent stroke.

Detailed Description

Stroke is a major cause of death and disability. A history of stroke is the strongest predictor of a future stroke. Control of risk factors lowers the risk of future stroke, yet most persons with stroke do not have their risk factors controlled. In this randomized-controlled trial, we will test whether an outpatient stroke prevention program consisting of group clinics, patient self-management, and telephone care coordination can lower the risk of recurrent stroke by improving patient knowledge, medication adherence, and lifestyle habits. If successful, this program may be adapted to other settings.

Registry
clinicaltrials.gov
Start Date
March 2010
End Date
May 2012
Last Updated
13 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Sepulveda Research Corporation
Responsible Party
Principal Investigator
Principal Investigator

Eric M. Cheng

Neurologist

Sepulveda Research Corporation

Eligibility Criteria

Inclusion Criteria

  • ischemic stroke within the past 30 days
  • transient ischemic attack within the past 30 days
  • person receiving care at VA Long Beach Healthcare System

Exclusion Criteria

  • unable to understand informed consent
  • already enrolled in another research study

Outcomes

Primary Outcomes

Blood pressure control

Time Frame: baseline, 3 months, 7 months

Secondary Outcomes

  • Stroke knowledge(baseline, 3 months, 7 months)
  • control of other stroke risk factors including lipids, smoking, and exercise(baseline, 3 months, 7 months)
  • patient perceptions of care quality(baseline, 3 months, 7 months)
  • medication adherence(baseline, 3 months, 7 months)

Study Sites (1)

Loading locations...

Similar Trials